Oxlumo Indication Expanded to Include Patients With Advanced PH1
The approval was based on data from the phase 3 ILLUMINATE-C study that included 21 dialysis-independent and -dependent patients with PH1.
Diagnosis & Disease Information
Effects of Climate Change on Older Adults
Climate change can affect older patients with asthma, COPD, allergies, kidney disease, and other conditions.
Therapeutic Peptide Granted Orphan Drug Status for Hepatorenal Syndrome
The Company is currently evaluating OCE-205 in a phase 2 trial in adults who have developed hepatorenal syndrome with acute kidney injury.
Novel Anticoagulant Therapy for Patients With ESRD Gets Fast Track Status
MK-2060 is an investigational monoclonal antibody designed to inhibit the activation of Factor XI and its ability to activate downstream proteins.
NephroScan Approved to Detect Renal Parenchymal Disorders
NephroScan is a sterile, single-dose kit for the preparation of technetium Tc 99m succimer injection for intravenous use.
Tarpeyo Now Available to Reduce Proteinuria in Primary IgA Nephropathy
To help patients gain access to treatment, Calliditas Therapeutics has launched a patient support program called Tarpeyo Touchpoints.
Purified Cortrophin Gel Now Available for Certain Chronic Autoimmune Disorders
The product is available through a network of specialty pharmacies and distributors.
Tarpeyo Approved to Reduce Proteinuria in Primary IgA Nephropathy
The approval was based on data from a phase 3 study that evaluated the efficacy and safety of Tarpeyo in 299 adults with primary IgAN.
FDA Approves Cortrophin Gel for Certain Chronic Autoimmune Disorders
Cortrophin Gel is a purified adrenocorticotropic hormone.
FDA to Review sNDA for Purified Cortrophin Gel for Multiple Indications
Purified Cortrophin Gel is a purified adrenocorticotropic hormone.
- Loading...
Loading...
Next post in News
Loading... 
Loading...